上海医药
上海醫藥
상해의약
SHANGHAI MEDICAL & PHARMACEUTICAL JOURNAL
2015年
15期
28-32
,共5页
肺结节%低剂量 CT%危险分层
肺結節%低劑量 CT%危險分層
폐결절%저제량 CT%위험분층
lung nodule%low dose CT%risk stratification
肺部结节的诊断和处理已成为临床医师日益受挑战的问题。目前,对于肺结节的干预措施主要包括定期影像随访、微创活检或手术治疗等,而相关患者的危险分层是选择何种干预措施的关键性因素。本文将从如何科学评估肺结节及肺结节临床处理原则两个方面展开论述。
肺部結節的診斷和處理已成為臨床醫師日益受挑戰的問題。目前,對于肺結節的榦預措施主要包括定期影像隨訪、微創活檢或手術治療等,而相關患者的危險分層是選擇何種榦預措施的關鍵性因素。本文將從如何科學評估肺結節及肺結節臨床處理原則兩箇方麵展開論述。
폐부결절적진단화처리이성위림상의사일익수도전적문제。목전,대우폐결절적간예조시주요포괄정기영상수방、미창활검혹수술치료등,이상관환자적위험분층시선택하충간예조시적관건성인소。본문장종여하과학평고폐결절급폐결절림상처리원칙량개방면전개논술。
The diagnosis and management of occasionally found lung nodule has become a big challenge to the physicians. Currently, the procedure for lung nodule treatment includes regular radiological follow-up, minimal invasive biopsy or surgery. However, the key factor for choosing right intervention is based on the risk level stratification of patients. In this article, scientific evaluation and clinical principle for managing lung nodule patients are discussed.